Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EKR Therapeutics Inc.

http://www.ekrtx.com/

Latest From EKR Therapeutics Inc.

EMA Says Yes To 12 New Drugs Including Pfizer/AbbVie’s Antibiotic Combo

Emblaveo, for fighting infections caused by multidrug-resistant bacteria, is among the latest batch of medicines that the European Medicines Agency says should be approved for use in the EU.

Europe Approvals

EMA Decision Time For Aztreonam-Avibactam; High-Stakes Meeting For Lecanamab

The European Medicines Agency is this week deciding whether a number of new drugs should win EU approval.

Europe Approvals

Japan's Biopharma Excellence Celebrated At 2nd Awards

Excellence, innovation, deal-making and personal achievement across the Japanese biopharma sector were celebrated at the Citeline Pharma Intelligence Awards Japan 2023, held in Tokyo on 17 October.

Japan Commercial

Japan's Biopharma Excellence Celebrated At 2nd Awards

Excellence, innovation, deal-making and personal achievement across the Japanese biopharma sector were celebrated at the Citeline Pharma Intelligence Awards Japan 2023, held in Tokyo on 17 October.

Japan Commercial
See All

Company Information

UsernamePublicRestriction

Register